Coronavirus vaccine trial begins in humans, Pfizer, BioNTech announce
The trial phase aims to enroll up to 360 patients, ages 18 to 55. Once the younger group produces sound evidence of safety and immunogenicity, testing in older adults, or those between the ages of 65 and 85, will begin. The news comes as researchers have created an antibody "that neutralizes SARS-CoV-2" in cells, offering the potential for prevention and treatment, a new study says.
Still, there is grim news: A revised mortality model predicts coronavirus-related deaths in the U.S. will nearly double to 135,000 through August as states ease social distancing restrictions.
Meanwhile, President Trump on Tuesday said Dr. Anthony Fauci will testify before the Senate, but that the White House will not allow him to testify in the House because he contends they are “a bunch of Trump haters.”
There is mounting evidence that the novel coronavirus can be transmitted by asymptomatic or presymptomatic individuals, a new review by the Centers for Disease Control and Prevention says.
Nearly all of the U.S. has been on lockdown to fight the spread of COVID-19, but newly published research by MIT economists argues that an "optimally targeted lockdown" could better protect the most vulnerable while also safeguarding the economy.
New York state is reporting more than 1,700 previously undisclosed deaths at nursing homes and adult care facilities as the state faces growing scrutiny on how it’s protecting its most vulnerable residents during the coronavirus pandemic.
California Gov. Gavin Newsom has denied a public records' request from the Los Angeles Times seeking details into a nearly $1 billion deal for protective masks from a Chinese car manufacturer. Newsom's office has been criticized over lack of transparency into the contract for weeks.
Tell others how they can get the latest news on coronavirus and more delivered daily to their inbox. Sign up here.
America Together: Send us your photos and we'll tell your story as the nation battles coronavirus.
And there were several other developments: